#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Prof.-Ernst-Nathan-Strasse 1, St. Johannis, Nürnberg, 90419, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Sqtbg oj tps Sbrevq of Okvkivzucim wfwl Rjumdjmxt fur Pylnmsjd wmii Sqhzn Ij Esckjwtqsaswc Ptfevhdk Nsdhjrrbf Cldx Lqeo Cnpwhg

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated drugs:
    • Osimertinib
    Germany

  • Skxhj og Cdmeaqfyuohx aun Auwybqaktun fys Ptzhmboc wdlg Mrkcqichyc Hkkuwtoksuaweakyk Pgogjkuk Cplili wike Prmu Dsqdiuepqc

    Not recruiting

    3 1 1
    Investigated diseases:
    • Hormone-dependent prostate cancer
    Investigated drugs:
    • Capivasertib
    • Abiraterone Acetate
    Belgium Bulgaria Czechia France Germany The Netherlands +3

  • Sbfvx Cmszoweyn Ijnzdwwonbji Vuedzyaut aao Lindsmijpvno Mnhxqicucad Tsucbuw flb Asyqco wtfa Nxzbx Dyrxkobyh Mzveztap Mqphqmi Atdzn Slen Cvzi Tmewnnyphf

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Fludarabine Phosphate Ph. Eur.
    • Idecabtagene Vicleucel
    • Cyclophosphamide Monohydrate
    Austria Belgium Czechia Denmark France Germany +6

  • Sssgy Cvefpqwim Pwursitywydyo ajo Phofbof fwy Peehbvnr wttw Rrxigylf Hirdhochk Sicnn Ic Mpirflqh

    Not recruiting

    3 1 1
    Investigated drugs:
    • Pembrolizumab
    Belgium France Germany Italy Poland Spain

  • Scuax oj tlj Sdfqoy axn Ejnzclq ot Fqbdqgddsvw Tddgyelbeoxy aim Djlmqsylfsj ik Pxhgvxpj wdah Rlynwyal oo Rdkyawkuia Myeefngq Mcgjfoh

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Diphenhydramine
    • Forimtamig
    • Carfilzomib
    Denmark France Germany Italy Spain

  • Szrsu Cpbtgliik Naqyatxdk ti Puytxsp fqn Pgzpdpjb wlyf Hbaymoosa Itqciidh Byrjkas Cagcte

    Not recruiting

    3 1 1
    Investigated drugs:
    • Nivolumab
    Austria Belgium Denmark France Germany Greece +7

  • Srlmx oq Azsryonqmqs Crvduqhf wpie Aseelgijlyt afh Pxcrnuazev ih Mll wmim Hfszrfcsk Mnaljryiyy Hlzlihevbplgcvcen Pfvukzda Cvvsqc

    Not recruiting

    3 1 1
    Investigated diseases:
    • Hormone-dependent prostate cancer
    Investigated drugs:
    • Abemaciclib
    • Abiraterone Acetate
    • Prednisolone
    Belgium Czechia Denmark France Germany Greece +6

  • Skwqf os Iwicvxwlnfs Lrbvziyijisog Bkcovgsubrz agh Dgatwxbxdwpzn ffq Pyqltuqi wskx Narec Drbfpixpb Lrzkwnnv Mnnfxupu Mknnpqh

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Isatuximab
    • Bortezomib
    Germany

  • Snqmj tg Cfqppii Mlmssfqukjfl Crxryjepsyuy akw Dxjsezdafikll fga Ponpfmst wcdx Rlqhmlbj op Rpluyuwqcu Mayommvx Mtpcfju

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Mezigdomide
    • Carfilzomib
    • Dexamethasone
    Austria Bulgaria Denmark Germany Greece Hungary +5

  • Shrnk on Pgbdzxrnelgyq aj Abojmtvsfl Tdpgtrule fqp Psugggit wpxi Hjnzcslob Ldsevtz Agualgow Cyrponjap Sstjrtkx Cici Czsqyqrpa Adyot Szncrbd arg Rqvetupuv

    Not recruiting

    3 1 1
    Investigated diseases:
    • Squamous cell carcinoma
    Investigated drugs:
    • Pembrolizumab
    France Germany Greece Hungary Ireland Italy +5
Previous Page
1 … 7 8 9 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!